Moroccan MedTech leader T2S Group Holding debuts on Casablanca Stock Exchange

T2S Group Holding, Morocco's leading medical technology (MedTech) company, made its stock market debut on the Casablanca Stock Exchange on Monday, marking the exchange's first initial public offering (IPO) of 2026. The operation raised nearly MAD 1.1 billion, combining a MAD 350 million capital increase and a MAD 750 million share sale.

The IPO attracted more than 110,000 subscribers and was 43 times oversubscribed, reflecting strong investor appetite for both the company and Morocco's healthcare sector. Shares were priced at MAD 223, with 1,569,506 new shares issued and 3,363,228 existing shares sold.

Founded in 1992 by Abderraouf Sordo, T2S employs more than 410 people and partners with major international MedTech companies including GE HealthCare, BioMérieux, Accuray and Boston Scientific. The group supplies, installs and maintains medical equipment for public and private healthcare providers while also producing radiopharmaceuticals through its subsidiary Cyclopharma and developing AI-powered hospital software via Binarios.

T2S generated MAD 1.76 billion in revenue in 2025, with 46% of its income coming from recurring activities. The company aims to reach MAD 4.17 billion in annual revenue by 2030, using the proceeds from the IPO to accelerate innovation, expand across Africa, strengthen local manufacturing and pursue targeted acquisitions. Already operating in more than 20 African countries, the group plans to further grow its continental footprint.